U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...

The April 11 order directs an immediate halt on manufacturing, sale, and distribution of these drugs, citing that they were ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...